PathoVax's Seed VC Round

PathoVax raised a round of funding on August 31, 2018. Investors include United Heath Investments.

PathoVax is a biotech company developing a cost-effective human papillomavirus (HPV) vaccine machine with universal protection. PathoVax's pilot vaccine RGVax promises to provide protection against al…

Articles about PathoVax's Seed VC Round: